- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BofA Securities
Recent news which mentions BofA Securities
Merck's Oral COVID-19 Treatment Could Be Game-Changer: BofA Analyst
October 06, 2021
From Benzinga
BofA Downgrades Takeda On Suspension Narcolepsy Drug Trials
October 06, 2021
Tickers
TAK
From Benzinga
Columbia Sportswear Analyst Downgrades Retailer On Supply Chain Woes
October 05, 2021
From Benzinga
From Benzinga
For Astra Space, Timing Is Critical: Analyst
October 04, 2021
From Benzinga
From Benzinga
BofA Initiates Upwork At Buy On Shift To Remote Workforce
October 01, 2021
Tickers
UPWK
From Benzinga
BofA Bearish On Foot Locker After Nike Warns Of Supply Chain Issues
September 30, 2021
From Benzinga
Why 2 EV Charging Stocks Face 'Offsetting Risks' To 'Outsized Opportunity'
September 30, 2021
From Benzinga
Why Micron Analysts Are Holding Bullish Bias Despite Weak Q1 Guidance
September 29, 2021
From Benzinga
Why BofA Cuts Micron Price Target, But Still Likes The Stock
September 29, 2021
From Benzinga
Nike Sees Strong Demand, But Supply Hurdles Hurt Guidance: Analyst
September 24, 2021
Tickers
NKE
From Benzinga
Why BofA Remains A Disney Bull Despite Disappointing Q4 Outlook
September 22, 2021
Tickers
DIS
From Benzinga
This Nimble EV Stock Has Outperformed Tesla And Other Major Automakers In September
September 21, 2021
From Benzinga
How Is Apple's China Risk-Reward Scenario Playing Out?
September 21, 2021
From Benzinga
How Preorders For Apple's iPhone 13 Models Are Tracking
September 20, 2021
From Benzinga
Pfizer, BioNTech Analysts On FDA Panel's COVID-19 Booster Dose Decision
September 20, 2021
From Benzinga
Moderna Analysts Debate Need For Biopharma's COVID-19 Booster Shot
September 16, 2021
From Benzinga
Why This Analyst Sees a Bumpy Ride Ahead For Lordstown
September 16, 2021
From Benzinga
Why This Lucid Group Analyst Says It's Among 'Most Legitimate' EV Startups
September 15, 2021
From Benzinga
Nvidia, AMD Benefit From New Products, Strong Gaming Cycle: BofA
September 08, 2021
From Benzinga
BofA Downgrades Alkermes After Stock Rally: 'We Don't See A Favorable Catalyst Pathway'
September 02, 2021
Tickers
ALKS
From Benzinga
What's Ailing Nio? Chinese EV Stock Underperforms Domestic Peers In August
September 01, 2021
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.